These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28883271)

  • 21. Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.
    Puccini B; Nassi L; Minoia C; Volpetti S; Ciancia R; Riccomagno PC; Di Rocco A; Mulè A; Toldo C; Sassone MC; Guariglia R; Filì C; Finolezzi E; Falorio S; Zanon S; Furlan A; Doa G; Zaja F;
    Ann Hematol; 2017 Jul; 96(7):1147-1153. PubMed ID: 28451805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose nivolumab induced remission in refractory classical Hodgkin lymphoma.
    Hwang YY; Khong PL; Kwong YL
    Ann Hematol; 2017 Jul; 96(7):1219-1220. PubMed ID: 28434018
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination chemoradiotherapy in early Hodgkin lymphoma.
    André MP
    Hematol Oncol Clin North Am; 2014 Feb; 28(1):33-47. PubMed ID: 24287066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncommon presentations of Hodgkin's disease. Case 2. Hodgkin's disease of the nasopharynx.
    Hollander SL
    J Clin Oncol; 2004 Jan; 22(1):195-6. PubMed ID: 14701783
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma].
    Kluge R; Körholz D
    Klin Padiatr; 2011 Nov; 223(6):315-9. PubMed ID: 22012607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas.
    Kostakoglu L
    Clin Lymphoma Myeloma; 2008 Oct; 8(5):273-6. PubMed ID: 18854280
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnostics, prognosis factors, and treatment of malignant lymphoproliferative disease, Hodgkin Disease].
    Sivkovich SO; Kysel'ova OA
    Lik Sprava; 2012; (1-2):56-63. PubMed ID: 23035600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematuria--a rare presentation of Hodgkin lymphoma.
    Dembla V; Walker BN; Elkins SL; Files JC
    Clin Adv Hematol Oncol; 2011 Oct; 9(10):788-90; discussion 791-2. PubMed ID: 22252582
    [No Abstract]   [Full Text] [Related]  

  • 29. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.
    Moog F; Bangerter M; Kotzerke J; Guhlmann A; Frickhofen N; Reske SN
    J Clin Oncol; 1998 Feb; 16(2):603-9. PubMed ID: 9469348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent positron emission tomography positivity secondary to benign histiocytic proliferation after treatment of Hodgkin lymphoma.
    Chumsri S; Tummala MK; Khna AM; Zhao XF; Rapoport AP
    Leuk Lymphoma; 2007 Mar; 48(3):616-8. PubMed ID: 17454607
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of Lymphoma Therapy Using (18)F-FDG PET.
    Lowe VJ; Wiseman GA
    J Nucl Med; 2002 Aug; 43(8):1028-30. PubMed ID: 12163627
    [No Abstract]   [Full Text] [Related]  

  • 32. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma.
    El-Galaly TC; d'Amore F; Mylam KJ; de Nully Brown P; Bøgsted M; Bukh A; Specht L; Loft A; Iyer V; Hjorthaug K; Nielsen AL; Christiansen I; Madsen C; Johnsen HE; Hutchings M
    J Clin Oncol; 2012 Dec; 30(36):4508-14. PubMed ID: 23150698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Controversial aspects in the current treatment of Hodgkin's disease].
    Vicente J
    Rev Clin Esp; 1987 Feb; 180(3):158-64. PubMed ID: 2437622
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.
    Pelosi E; Penna D; Douroukas A; Bellò M; Amati A; Arena V; Passera R; Bisi G
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):469-75. PubMed ID: 21150862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin in a Hodgkin lymphoma.
    Brahimi M; Attaf F; Arabi A; Bekadja MA
    Hematol Oncol Stem Cell Ther; 2013 Jun; 6(2):68-70. PubMed ID: 23774179
    [No Abstract]   [Full Text] [Related]  

  • 37. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
    Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancytopenia with myelofibrosis. An unusual presentation of childhood Hodgkin's disease.
    Carroll WL; Berberich FR; Glader BE
    Clin Pediatr (Phila); 1986 Feb; 25(2):106-8. PubMed ID: 3753669
    [No Abstract]   [Full Text] [Related]  

  • 39. The infiltration of classical Hodgkin lymphoma cells into pleural effusion.
    Kito M; Munakata W; Ono K; Maeshima AM; Matsushita H
    Int J Hematol; 2018 Jan; 107(1):1-2. PubMed ID: 28900852
    [No Abstract]   [Full Text] [Related]  

  • 40. [The treatment of patients with refractory forms of Hodgkin's lymphomas].
    Hubareva HO; Kriachok IA; Tytorenko IB; Aleksyk OM; Novosad OI; Kadnikova TV; Martynchyk AV; Pastushenko IaV; Filonenko KS; Kushchevyĭ IeV
    Lik Sprava; 2010; (1-2):115-8. PubMed ID: 20608037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.